WELLS FARGO & COMPANY/MN
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in PHAT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$512,315
-$616,070 QoQ
Shares Held
46,113
-32.2% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. PHAT ranks #127 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in PHAT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $512,315 | 46,113 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,128,385 | 68,016 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $631,436 | 53,648 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $447,642 | 46,678 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $178,224 | 28,425 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $207,189 | 25,516 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $326,416 | 18,054 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $178,344 | 17,315 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $123,245 | 11,605 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $99,425 | 10,890 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $75,431 | 7,274 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $137,443 | 9,598 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $33,743 | 4,726 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $4,509 | 407 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,055 | 599 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,844 | 1,605 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $172,957 | 8,793 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $132,474 | 3,527 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $375,020 | 11,289 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $316,352 | 8,627 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $378,695 | 11,507 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $162,640 | 6,299 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||